by Clare Gerrard | Jan 31, 2023
Neuroendocrine Cancer UK has been made aware that there is an imminent issue regarding the availability of Olatuton® (Octreotide long-acting) somatostatin analogue injections. This is due to a legal issue that has led to the withdrawal of Olutaton®: it will not be... by Leanne Talbot | Jun 30, 2021
Name: Sophie Age: 52 Neuroendocrine Cancer Site: Glucagonoma – pancreas (primary), paraaortic retroperitoneal lymph nodes (secondary). Sophie’s Story: When is a rash not a rash? My NET story probably begins some time before 2014, but that is the year I... by Leanne Talbot | Jun 17, 2021
Name: Deborah Age: 60 Neuroendocrine Cancer Site: Primary to small bowel. Metastasis to liver. Deborah’s story: I was diagnosed in February 2016 with small bowel Neuroendocrine Cancer with liver metastasis. For years I thought I was going through the... by Leanne Talbot | Apr 20, 2021
Please join us in welcoming our newest Ambassador, Simon to the team 🦋 Simon is 38, husband to Amy and father to three girls. Previously a Senior Vice Principal in secondary education. Here’s Simon’s story: 💬 I was diagnosed in October 2018 (aged 35)... by Leanne Talbot | Apr 15, 2021
NHS Cancer Care At Home – At the end of March NHS England & NHS Improvement issued the following statement: ‘Covid-Friendly’ Cancer Care At Home Extended For More Patients Thousands of people with cancer can benefit from ‘Covid friendly’ treatments from... 
